UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European respiratory review, ISSN 0905-9180, 09/2011, Volume 20, Issue 121, pp. 156 - 174
Diagnosis | Management | Pulmonary | Risk factors | Aspergillosis | Invasive Pulmonary Aspergillosis - drug therapy | Predictive Value of Tests | Pulmonary Aspergillosis - drug therapy | Aspergillosis, Allergic Bronchopulmonary - microbiology | Risk Assessment | Humans | Risk Factors | Treatment Outcome | Pulmonary Aspergillosis - diagnosis | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Pulmonary Aspergillosis - microbiology | Invasive Pulmonary Aspergillosis - diagnosis | Antifungal Agents - therapeutic use | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Hypersensitivity | Lung diseases | Mortality | Antifungal agents | Aspergilloma | Immunodeficiency | Chronic infection | Cystic fibrosis | Allergic diseases | Inflammation | Malignancy | Immune status | Allergic bronchopulmonary aspergillosis | Epidemiology | Asthma | Atopy | Cavities | Reviews | Chronic obstructive pulmonary disease | Index Medicus | diagnosis | pulmonary | risk factors | management
Journal Article
The European respiratory journal, ISSN 0903-1936, 01/2016, Volume 47, Issue 1, pp. 45 - 68
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Antifibrinolytic Agents - therapeutic use | Pulmonary Aspergillosis - complications | Humans | Aspergillosis, Allergic Bronchopulmonary - complications | Pulmonary Aspergillosis - therapy | Tomography, X-Ray Computed | Lung - diagnostic imaging | Pulmonary Aspergillosis - immunology | Antifungal Agents - therapeutic use | Aspergillosis, Allergic Bronchopulmonary - therapy | Thoracic Surgery, Video-Assisted | Bronchial Arteries | Immunocompetence | Embolization, Therapeutic - methods | Mycetoma - complications | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Bronchoscopy | Invasive Pulmonary Aspergillosis - therapy | Invasive Pulmonary Aspergillosis - immunology | Mycetoma - immunology | Pulmonary Aspergillosis - diagnosis | Tranexamic Acid - therapeutic use | Invasive Pulmonary Aspergillosis - diagnosis | Hemoptysis - therapy | Aspergillosis, Allergic Bronchopulmonary - immunology | Mycetoma - diagnosis | Disease Management | Mycetoma - therapy | Immunocompromised Host | Lung - surgery | Chronic Disease | Invasive Pulmonary Aspergillosis - complications | Hemoptysis - etiology | Index Medicus
Journal Article
Thorax, ISSN 0040-6376, 03/2015, Volume 70, Issue 3, pp. 270 - 277
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Pathogens | Transplants & implants | Pathogenesis | Lung diseases | Mortality | Cystic fibrosis | Infections | Risk factors | Asthma | Chemotherapy | Surveillance | Medical prognosis | Bronchitis | Health risk assessment | Steroids | Neutropenia | Index Medicus
Journal Article
Respiratory medicine, ISSN 0954-6111, 08/2018, Volume 141, pp. 121 - 131
Aspergillus | Chronic pulmonary aspergillosis | Invasive aspergillosis | Pulmonary aspergillosis | Allergic bronchopulmonary aspergillosis | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Invasive Pulmonary Aspergillosis - drug therapy | Recurrence | Triazoles - administration & dosage | Pulmonary Aspergillosis - drug therapy | Prognosis | Pyridines - administration & dosage | Humans | Environmental Exposure - prevention & control | Pulmonary Aspergillosis - diagnosis | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Pulmonary Aspergillosis - microbiology | Invasive Pulmonary Aspergillosis - diagnosis | Antifungal Agents - therapeutic use | Environmental Exposure - adverse effects | Fungi | Nitriles - administration & dosage | Pulmonary Aspergillosis - epidemiology | Aspergillus - isolation & purification | Aspergillosis, Allergic Bronchopulmonary - diagnosis | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Sleep disorders | Medical colleges | Triazoles | Communicable diseases | Cystic fibrosis | Respiratory agents | Drug approval | Risk factors | Therapy | Regulatory agencies | Medical imaging | Microbiology | Mycology | Medical treatment | Molds | Infections | Medical diagnosis | Patients | Asthma | Infectious diseases | Classification | Aspergillosis | Chronic obstructive pulmonary disease | Diagnosis | Clinical microbiology | Immune system | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2011, Volume 52, Issue 9, pp. 1123 - 1129
Polymerase chain reaction | Antifungals | Aspergillus | Azoles | Triazoles | Aspergillosis | Sputum | ARTICLES AND COMMENTARIES | Allergic bronchopulmonary aspergillosis | Aspergillus fumigatus | Genetic mutation | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Aspergillus fumigatus - drug effects | Sputum - microbiology | Lung - microbiology | Aspergillosis, Allergic Bronchopulmonary - microbiology | Humans | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Antifungal Agents - therapeutic use | Bronchoalveolar Lavage Fluid - microbiology | Aspergillus fumigatus - isolation & purification | Culture Media | Polymerase Chain Reaction | Aspergillosis, Allergic Bronchopulmonary - epidemiology | Invasive Pulmonary Aspergillosis - epidemiology | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Invasive Pulmonary Aspergillosis - drug therapy | Pulmonary Aspergillosis - drug therapy | DNA, Fungal - analysis | Drug Resistance, Fungal - genetics | Aspergillus fumigatus - genetics | Pulmonary Aspergillosis - microbiology | Triazoles - pharmacology | Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - microbiology | Mutation | Chronic Disease | Drug resistance in microorganisms | Usage | Physiological aspects | Causes of | Lung diseases, Fungal | Research | Drug therapy | Health aspects | Fungi | Medical diagnosis | Deoxyribonucleic acid--DNA | Nonnative species | Polymorphism | Index Medicus | and Commentaries
Journal Article
6.
Full Text
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
Clinical microbiology and infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1882 - 1889
invasive aspergillosis | voriconazole | galactomannan | Epidemiology | outcome | Galactomannan | Invasive aspergillosis | Outcome | Voriconazole | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Aspergillus - classification | Prospective Studies | Humans | Middle Aged | Male | Antifungal Agents - therapeutic use | Incidence | Young Adult | Aged, 80 and over | Aspergillus - isolation & purification | Adult | Female | Seasons | Invasive Pulmonary Aspergillosis - epidemiology | Invasive Pulmonary Aspergillosis - drug therapy | France - epidemiology | Risk Factors | Invasive Pulmonary Aspergillosis - mortality | Drug Therapy, Combination - methods | Hospitals | Invasive Pulmonary Aspergillosis - microbiology | Mannans - blood | Adolescent | Aged | Immunocompromised Host | Analysis | Leukemia | Aspergillosis | Stem cells | Transplantation of organs, tissues, etc | Respiratory tract diseases | Transplantation | Risk factors | Trends | Transplants & implants | Mortality | Cell culture | Risk groups | Lung | stem cell transplantation | Central nervous system | Immunoproliferative diseases | Lipids | Regression analysis | Inflammatory diseases | Seasonal variations | Caspofungin | Geriatrics | Tumors | Index Medicus | Life Sciences | Aspergillus | Microbiology and Parasitology | Invasive Pulmonary Aspergillosis | Mannans | Antifungal Agents | Drug Therapy, Combination | France
Journal Article
Clinical microbiology and infection, ISSN 1198-743X, 05/2018, Volume 24, pp. e1 - e38
Invasive fungal infection | Transplantation | Haematology | Treatment | Diagnosis | Aspergillosis | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biopsy - methods | Nitriles - pharmacology | Voriconazole - pharmacology | Humans | Bronchoalveolar Lavage | Aspergillosis - diagnosis | Tomography, X-Ray Computed | Leukemia, Myeloid, Acute - complications | Itraconazole - pharmacology | Mannans - analysis | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Myelodysplastic Syndromes - therapy | Aspergillus - isolation & purification | Aspergillosis - complications | Leukemia, Myeloid, Acute - therapy | Aspergillosis - drug therapy | Pyridines - therapeutic use | Triazoles - therapeutic use | Antifungal Agents - pharmacology | Immunologic Tests | Aspergillus - immunology | Voriconazole - therapeutic use | Antibodies, Fungal - blood | Myelodysplastic Syndromes - complications | Invasive Pulmonary Aspergillosis - diagnosis | Aspergillus - drug effects | Itraconazole - therapeutic use | Triazoles - pharmacology | Magnetic Resonance Imaging | Flucytosine - therapeutic use | Disease Management | Pyridines - pharmacology | Flucytosine - pharmacology | Immunocompromised Host | Early Diagnosis | Aspergillosis - immunology | Nitriles - therapeutic use | Index Medicus | Life Sciences | Microbiology and Parasitology | Immunology | Bacteriology | Virology
Journal Article